Some women cannot take estrogen. A history of breast cancer, a previous clot, a stroke. Others simply do not want to, and that is a legitimate position that deserves a real answer rather than a shrug and a leaflet about layered clothing.

Until recently the honest answer was thin. It is not thin any more.

No Hormones Required

A drug class that works on the brain's thermostat itself. Not a supplement. A mechanism.

First, the Sentence That Frames Everything

Hormone therapy is still the most effective treatment for hot flashes. Nothing here beats it. Everything below is for the woman who cannot have it or has decided against it, and she deserves to know she is choosing a good second option rather than being told a second option is just as good.

The New Drugs, and Why They Are Different

For decades the non-hormonal options were medicines borrowed from other conditions: antidepressants, an antiseizure drug, a bladder drug. They helped, modestly, by accident.

Then researchers worked out what actually causes a hot flash. Deep in the hypothalamus sits a cluster of nerve cells known as KNDy neurons, named for the three signalling molecules they use: kisspeptin, neurokinin B and dynorphin. They sit next to the brain's temperature control center. Estrogen quiets them. When estrogen falls at menopause, neurokinin B signalling rises, the neurons fire without restraint, and the thermostat misreads your body as overheating. It then does what it would do if you really were: flushes the skin and opens the sweat glands.

That is why estrogen works. And it is why blocking the neurokinin 3 receptor works too, without any estrogen at all.

For the first time, a drug aimed at the actual mechanism of a hot flash, rather than borrowed from another illness.

Fezolinetant

The first of the class. In a phase 3 trial of over 500 postmenopausal women with moderate to severe hot flashes, both doses beat placebo significantly. The mean reductions in hot flash frequency at 12 weeks:

64%  |  59%  |  45% Fezolinetant 45 mg, fezolinetant 30 mg, and placebo. Note how much placebo alone achieves. Women on 45 mg also had significant improvement in sleep disturbance.

The safety condition attached to it is not optional. After cases of serious drug-induced liver injury emerged in postmarketing use, the FDA now requires liver enzymes and bilirubin before starting, then monthly for the first three months, then at six and nine months. It must not be started if any result is at or above twice the upper limit of normal, and must be stopped for any sign of liver trouble, or if transaminases exceed five times normal.

If you are offered this drug without blood tests, that is a reason to change doctors.

Elinzanetant

A dual neurokinin 1 and 3 receptor antagonist, taken as 120 mg daily. It reduces both the frequency and the severity of hot flashes, and baseline liver tests are recommended as with fezolinetant.

It has one property that matters enormously to a particular group: it is effective for hot flashes caused by endocrine therapy for breast cancer. For a woman on tamoxifen or an aromatase inhibitor, drenched at night, previously offered almost nothing, that is a genuine change.

The Older Options, Used Properly

These still have a place, and choosing between them is not arbitrary.

SSRIs and SNRIs. The most effective of the older alternatives. Two things to know. The response is fast, within days rather than the weeks it takes for depression, so you know quickly whether it is working. And the choice of molecule matters:

One trial worth knowing: venlafaxine 75 mg gave similar hot flash relief to low dose oral estradiol 0.5 mg. The difference is what happens next. Pushing the estradiol dose up can abolish flashes altogether; pushing the venlafaxine up generally will not.

Gabapentin, used at night. This is where it is genuinely elegant. Nocturnal hot flashes cluster in the first four hours of sleep, and REM sleep in the later hours suppresses them. So a single bedtime dose covers the window that actually wakes you. Start at 100 mg an hour before bed and increase by 100 mg every three nights until the flashes settle, side effects appear, or you reach 900 mg. Women often report that even when a night sweat happens, they fall back asleep more easily than before.

At much higher doses gabapentin approaches estrogen for efficacy: in one small trial, gabapentin titrated to 2,400 mg, conjugated estrogen 0.625 mg and placebo reduced hot flash severity scores by 72, 71 and 54 percent. But at that dose it caused headache, dizziness and disorientation, which is why nobody uses it that way.

Oxybutynin. Better than placebo at 5 to 10 mg daily, but dry mouth affected 20 to 30 percent in one trial and 50 percent in another, and observational data link anticholinergic drugs to increased dementia risk in older adults. We use it rarely, and for that reason.

Cognitive behavioral therapy. Modest for hot flashes, better for the insomnia around them. In a trial of 106 peri- and postmenopausal women with insomnia and hot flashes, an eight-week telephone-based CBT for insomnia moved 70 percent of women into the "no insomnia" range, against 24 percent with menopause education alone. It reduced how much hot flashes bothered them without reducing how often they occurred, which is a distinction worth understanding before you judge whether it worked.

What Does Not Work, and Why You Believed It Did

This section will annoy some readers. It is also the most valuable part of the page, because it protects your money and your time.

The Menopause Society's 2023 non-hormone position statement explicitly does not recommend: paced respiration, supplements and herbal remedies, cooling techniques, avoiding triggers, exercise, yoga, mindfulness-based intervention, relaxation, soy, cannabinoids, acupuncture, and clonidine.

The specifics:

Now the reason all of these have devoted believers.

20 to 50 percent The placebo response in hot flash trials. Start anything during a bad month and it will appear to work. This is why a remedy must beat placebo in a controlled trial before it means anything.

Two honorable exceptions worth naming. Exercise remains one of the best things you can do for your body, for bone, muscle, heart and mood; it simply does not treat hot flashes. And weight loss does appear to help: in a six-month trial, an intensive behavioral weight loss program improved hot flashes compared with a health education control among women who were overweight and bothered by symptoms.

How Long Will You Need It

Longer than you have probably been told. In the Study of Women's Health Across the Nation, among 1,449 women with vasomotor symptoms, the median total duration was 7.4 years, persisting a median of 4.5 years after the final period. Women whose symptoms began before their periods stopped had the longest course, over 11.8 years.

For non-hormonal drugs, the usual approach is to taper after about two years and see whether the flashes have gone. If they have not and remain troublesome, treatment resumes and the taper is tried again later. SSRIs and SNRIs must always be tapered rather than stopped abruptly.

If estrogen is not an option for you, there is now a real answer. It just has to be prescribed carefully.

Message us on WhatsApp

One Thing to Rule Out First

Not every flush is menopause. Thyroid overactivity, certain medications, infection, and rarely carcinoid syndrome or a phaeochromocytoma can all cause flushing and sweats. If your symptoms are atypical, if they came with weight loss or palpitations, or if they do not respond to sensible treatment, the diagnosis deserves revisiting rather than the dose being pushed. That is the internal medicine half of this practice, and it is the half most hormone clinics do not have.

Where These Figures Come From

Related Reading